Why the study?
Catheter ablation for persistent AF remains less effective than for paroxysmal AF, and randomized trials of empirical adjunctive ablation beyond PVI have produced inconsistent or neutral results.
Population
Patients with persistent atrial fibrillation
Design
Pro and contra review article
Answers are grounded in this paper and cite their sources.
Catheter ablation for persistent atrial fibrillation remains less effective than for paroxysmal atrial fibrillation, despite pulmonary vein isolation (PVI) forming the foundation of both procedures. Ablating beyond the pulmonary veins, including treatment of non-pulmonary vein triggers, posterior wall isolation, linear lesions, vein of Marshall ethanol infusion, isolation of the superior vena cava, coronary sinus or left atrial appendage, and modification of regions identified by fibrosis or low voltage has grown interest. Although observational and mechanistic studies have often been encouraging, randomized trials of empirical adjunctive ablation have produced inconsistent or neutral results. Pulsed field ablation has renewed the debate by facilitating rapid ablation of extra-pulmonary vein tissue. The PIFPAF-PFA trial did not demonstrate a significant reduction in its primary endpoint of atrial tachyarrhythmia recurrence lasting at least 30 seconds with adjunctive posterior wall isolation. However, separation of the recurrence curves and exploratory signals for reduced arrhythmia burden and fewer prolonged episodes raise questions about lesion strategy and the clinical relevance of conventional recurrence definitions. These findings do not establish routine posterior wall isolation, but they illustrate why a neutral binary endpoint may not fully characterize treatment effects on recurrent AF. The controversy now extends beyond whether additional ablation is beneficial to which mechanisms should be targeted, which patients should receive adjunctive lesions, how energy source affects lesion durability and safety, and whether success should be defined by any brief recurrence or by clinically meaningful arrhythmia burden. This article examines the evidence supporting and opposing ablation beyond PVI in persistent AF.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: